Memorial Şişli Hospital
Memorial Şişli Hospital
Turchia, Istanbul
Serkan Keskin
25 anni di esperienza
accreditamenti :
Clinica certificata da :
| Turchia | Austria | Spagna | |
| Terapia ormonale | da $399 | da $7,000 | da $3,000 |
| Terapia di deprivazione androgenica | da $1,500 | da $4,500 | da $3,200 |
| Terapia ormonale per il cancro alla prostata | - | - | da $2,278 |
Giorno 1 - Arrivo
Giorno 2 - Consultazione pre-operatoria
Giorno 3 - Risultati degli esami e piano di trattamento
Giorno 4 - Inizio della terapia ormonale
Dal giorno 5 al 14 - Continuazione della terapia
Settimana 3 - Monitoraggio post-operatorio
Settimana 4 - Riabilitazione
Settimana 6
Settimana 8
Si prega di notare che questa è una guida generale e le esperienze individuali possono variare. Consultare sempre il proprio operatore sanitario per una consulenza personalizzata.
Fellowship presso l'Istituto Tumori dell'Università di Hacettepe – Il Dr. Solak è specializzato nella terapia ormonale per diversi tipi di cancro.
Il medico è un oncologo molto rispettato presso l'Anadolu Medical Center, specializzato in oncologia medica e chemioterapia. Dopo aver conseguito una laurea in medicina presso l'Università di Ankara nel 2005, il medico ha completato la formazione specialistica in medicina interna presso l'Università di Istanbul e si è ulteriormente specializzato in oncologia medica presso l'Università di Marmara entro il 2017. Il medico ha guidato l'unità di oncologia medica presso l'Ospedale di Formazione e Ricerca Haydarpaşa Numune e ha partecipato a numerosi studi clinici internazionali. Il medico si concentra su un'ampia gamma di tumori, inclusi quelli al seno, urologici, polmonari e gastrointestinali, tra gli altri.<\/p>
Il medico è membro di diverse società oncologiche prestigiose, tra cui la Società Turca di Oncologia Medica, la Società Europea di Oncologia Medica e la Società Americana di Oncologia Medica. Il medico ha partecipato a programmi di formazione avanzata a livello globale, inclusi programmi presso l'Università di Oxford e ESMO.<\/p>
Dr. Abdullah Sakin is a medical oncologist at Medipol Bahçelievler University Hospital in Istanbul. He specializes in treating complex cancers, including lung, breast, and gastrointestinal malignancies. Dr. Sakin previously served as the Head of the Medical Oncology Department at Yüzüncü Yıl University. He also held a leadership role at Prof. Dr. Cemil Taşçıoğlu City Hospital.
La professoressa Yesim Yildirim è specializzata in immunoterapia del cancro e terapie mirate, con oltre 80 pubblicazioni in oncologia medica.
Before starting hormone therapy, ask your specialist about the specific diagnostic panel required, the long-term monitoring schedule, and the exact hormone delivery method. Ensure the treatment plan aligns with international standards like those from the European Society of Medical Oncology or the World Professional Association for Transgender Health.
Bookimed Expert Insight: Bookimed data shows a significant quality gap between multi-specialty centers like Anadolu Medical Center and smaller boutique clinics. High-tier Turkish hospitals often use Joint Commission International standards and affiliate with institutions like Johns Hopkins, ensuring safer protocols. Patients should prioritize clinics with on-staff endocrinologists rather than general practitioners to avoid common side-effect management issues.
Patient Consensus: Patients warn that some clinics may skip comprehensive blood panels, leading to avoidable mood swings or physical complications. Others emphasize the importance of getting all prescriptions and medical reports in English to ensure seamless follow-up care back home.
Turkey requires patients to be at least 21 years old to access gender-affirming hormone therapy (GAHT), following recent 2025 and 2026 directives. Medical protocols now mandate approval from a seven-physician board and an electronic prescription system linked specifically to verified diagnostic codes for adulthood transition.
Bookimed Expert Insight: While official regulations have tightened, a major differentiator remains the facility choice. JCI-accredited centers like Anadolu Medical Center or Memorial Şişli Hospital strictly follow international safety standards. Patients often find that private oncology and endocrinology departments provide more consistent care than public hospitals where administrative hurdles are significantly higher.
Patient Consensus: Many individuals emphasize that while therapy is technically legal, navigating the bureaucratic system requires patience. Local trans communities remain the most reliable resource for identifying affirming providers who can streamline the complex board approval process.
Patients choose Turkey for hormone therapy to access high-quality medical expertise and immediate specialist consultations without the months-long waiting lists common in Western healthcare systems. Turkish facilities prioritize comprehensive diagnostic blood panels and advanced treatments like bioidentical hormone replacement within JCI-accredited clinics.
Bookimed Expert Insight: While lower costs are a major draw, the real advantage lies in the integration of specialized oncology and endocrinology departments. Clinics such as Memorial Şişli and Medipol Mega possess high-end diagnostic tools like the Da Vinci system. This allows them to manage complex hormone-sensitive cancers and metabolic disorders with a level of precision that smaller boutique clinics in Europe often cannot provide.
Patient Consensus: Patients often feel more respected and heard in Turkey compared to their home countries. They frequently praise the knowledgeable, progressive approach to care and the convenience of all-inclusive packages that bundle labs and initial prescriptions.
International patients choose Turkey for hormone therapy. They seek specialist oncology and endocrine expertise without the long waitlists common in Australia. Leading Istanbul centres provide systemic therapies for prostate and breast cancers. These treatments often save patients up to 94% compared to Australian private healthcare costs.
Bookimed Expert Insight: Anadolu Medical Center and similar hospitals are affiliated with Johns Hopkins Medicine. Their hormone therapy protocols for cancer follow the same rigorous standards as top-tier American hospitals. They do so at a fraction of the price.
Patient Consensus: Visitors appreciate the efficient coordination. They also value how specialists explain complex endocrine treatments in plain English. The speed of starting therapy in Turkey is a major relief. Patients used to public system delays appreciate this.
Using unregulated or illegal hormones in Turkey carries severe health and legal risks. This is due to strict e-prescription mandates and tightened pharmaceutical controls. Illicit sources often supply contaminated or incorrectly dosed substances. These can lead to life-threatening complications, such as thrombosis, stroke, or organ failure. This can happen in JCI-accredited environments or private settings.
Bookimed Expert Insight: While Turkey is a hub for oncology-based hormone therapy, transition-related access is heavily restricted. Research shows that pharmacies strictly enforce e-prescription rules for many products. Patients should secure a long-term supply from their home country before arrival. This helps them stay safe.
Patient Consensus: Turkish pharmacies are required to demand prescriptions for hormones. Patients report that unverified online sources have supplied dangerous substances. This can cause near-death hospitalisation or severe mental health crises. These often result from inconsistent dosages in Turkey.
Gender-affirming hormone therapy in Turkey requires a mandatory clinical pathway. This pathway involves psychiatric evaluation and endocrinological oversight. Patients must be over 18 for legal transition. However, new 2025 directives further restrict hormone prescriptions for those under 21. Major JCI-accredited centres mainly provide hormone therapy for oncological or reproductive purposes.
Bookimed Expert Insight: Turkey is a global hub serving over 60,000 international patients annually. However, gender-affirming hormone therapy is not available through private hospital systems popular with Australians. Leading facilities like Memorial Şişli Hospital specialise in hormone therapy for cancer care. However, transition-related hormones remain restricted to state-run psychiatric and endocrinological boards.
Patient Consensus: Patients find the official route involves long waitlists and multiple psychological evaluations across various departments. Obtaining a prescription for oestrogen or testosterone in Turkey now requires navigating the public health system. This replaces the option of visiting a private specialist.